Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer
NCT00352378
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
209
Enrollment
OTHER_GOV
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Anthracycline, Cyclophosphamide, Docetaxel, Capecitabine
Sponsor
National Cancer Center, Korea